[2013] HCATrans 124
IN THE HIGH COURT OF AUSTRALIA
Office of the Registry
Sydney No S219 of 2012
No S1 of 2013
B e t w e e n -
APOTEX PTY LTD ACN 096 916 148
Applicant/Appellant
and
SANOFI‑AVENTIS AUSTRALIA PTY LTD
First Respondent
SANOFI‑AVENTIS DEUTSCHLAND GMBH
Second Respondent
AVENTISUB II INCORPORATED
Third Respondent
FRENCH CJ
HAYNE J
CRENNAN J
KIEFEL J
GAGELER J
TRANSCRIPT OF PROCEEDINGS
AT CANBERRA ON WEDNESDAY, 29 MAY 2013, AT 10.18 AM
(Continued from 28/5/13)
Copyright in the High Court of Australia
____________________
FRENCH CJ: Yes, Mr Jackson.
MR JACKSON: Your Honours, when the Court adjourned I was referring the Court to the reasons for judgment of Justice Gummow in the Rescare Case 101 ALR 205 and, your Honours, I had passed over for a moment what appears at the top of page 234, the extract from the Australian Patent Office Patent Examiner’s Manual. Could I give your Honours copies of that now? Your Honours should have that.
The relevant parts dealing with human beings are in paragraph 35.79, your Honours, and in the passage that goes through to 35.81. Your Honours will see in 35.79 some references and then 35.80 the reference to Schering A.G. and Bernhard Joos v Commissioner of Patents. Then your Honours will see paragraph 35.81; it is simply the fuller version, I think, of what his Honour extracted in that decision.
Your Honours, I took your Honours yesterday to the next part of his Honour’s reasons dealing with the Industrial Property Advisory Committee’s views. Could I take your Honours to page 235 about point 9, and your Honours will see commencing at the bottom of that page the discussion that goes on page 236 to page 237 of Maeder v Busch and the other two cases in the Court. Then, your Honours, could I come to page 237 about point 4 to the reference to the New Zealand decision in Wellcome Foundation v Commissioner of Patents?
Your Honours, I will not attempt to go through this in detail, but may I just invite your Honours to read the discussion by his Honour. Could I take your Honours particularly to the observation at page 238, about point 2 on the page, where Justice Gummow quoted the reference by Chief Justice Davison to:
the lack of logic in any distinction which produced the result that a product for treating the human body would be patentable but not a method of treating the human body.
Your Honours will see the reference to the reversal of that decision by the New Zealand Court of Appeal and, your Honours, about line 38, to his Honour Justice Gummow’s view of the Australian experience. Then your Honours, at page 239, your Honours will see at about point 3 on the page, I suppose, about line 15, a reference, a response to point 5, which is referred to in 9, an argument on the other side that the patentee would be able to refuse to…
Keep reading for free
Create a free CaseChat account to read Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd & Ors and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2013] HCATrans 124
- Decision Date
CaseChat Overview and Summary
The central legal issue before the High Court was whether Apotex had breached its undertaking to Sanofi. This undertaking was given in the context of proceedings where Sanofi sought interlocutory relief to prevent Apotex from infringing its patent rights. The specific question was whether Apotex's actions in importing and selling the relevant pharmaceutical products constituted a breach of the terms of that undertaking.
The High Court analysed the nature and scope of the undertaking given by Apotex. It considered the ordinary meaning of the words used in the undertaking and the context in which it was given. The Court determined that the undertaking was intended to provide a specific form of protection to Sanofi during the period before the final determination of the patent dispute. By engaging in the conduct that was the subject of the proceedings, Apotex had acted in a manner that the Court found to be inconsistent with the plain meaning and intended effect of its promise to the court. The Court applied principles of contractual interpretation to the undertaking, treating it as a binding promise.
The High Court found that Apotex had breached its undertaking and accordingly dismissed the appeal.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi